{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:45:44Z","timestamp":1709081144173},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,27]]},"DOI":"10.7759\/cureus.55064","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T17:01:02Z","timestamp":1709053262000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Myosin Heavy Chain 9-Related Disorder Following Splenectomy Due to Misdiagnosis of Idiopathic Thrombocytopenic Purpura"],"prefix":"10.7759","author":[{"given":"Eren","family":"Arslan Davulcu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emin","family":"Karaca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nur","family":"Akad Soyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/79069","article-title":"Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly","volume":"26","author":"Kelley MJ","year":"2000","unstructured":"Kelley MJ, Jawien W, Ortel TL, Korczak JF. Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly. Nat Genet. 2000, 26:106-8. 10.1038\/79069","journal-title":"Nat Genet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/79063","article-title":"Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin\/Fechtner syndrome consortium","volume":"26","author":"Seri M","year":"2000","unstructured":"Seri M, Cusano R, Gangarossa S, et al.. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin\/Fechtner syndrome consortium. Nat Genet. 2000, 26:103-5. 10.1038\/79063","journal-title":"Nat Genet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.113.19.3353","article-title":"A myosin family tree","volume":"113 Pt 19","author":"Hodge T","year":"2000","unstructured":"Hodge T, Cope MJ. A myosin family tree. J Cell Sci. 2000, 113 Pt 19:3353-4. 10.1242\/jcs.113.19.3353","journal-title":"J Cell Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08716.x","article-title":"Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias","volume":"154","author":"Balduini CL","year":"2011","unstructured":"Balduini CL, Pecci A, Savoia A. Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias. Br J Haematol. 2011, 154:161-74. 10.1111\/j.1365-2141.2011.08716.x","journal-title":"Br J Haematol"},{"key":"ref5","article-title":"MYH9-related disease","author":"Savoia A","unstructured":"Savoia A, Pecci A. MYH9-related disease. GeneReviews\u00ae [Internet]. Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A (ed): University of Washington, Seattle (WA); 1-24."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.68","article-title":"Mutation spectrum and genotype-phenotype correlations in a large French cohort of MYH9-related disorders","volume":"2","author":"Saposnik B","year":"2014","unstructured":"Saposnik B, Binard S, Fenneteau O, Nurden A, Nurden P, Hurtaud-Roux MF, Schlegel N. Mutation spectrum and genotype-phenotype correlations in a large French cohort of MYH9-related disorders. Mol Genet Genomic Med. 2014, 2:297-312. 10.1002\/mgg3.68","journal-title":"Mol Genet Genomic Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1220327","article-title":"MYH9-related platelet disorders","volume":"35","author":"Althaus K","year":"2009","unstructured":"Althaus K, Greinacher A. MYH9-related platelet disorders. Semin Thromb Hemost. 2009, 35:189-203. 10.1055\/s-0029-1220327","journal-title":"Semin Thromb Hemost"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14217","article-title":"Thrombopoietin receptor agonists in hereditary thrombocytopenias","volume":"16","author":"Rodeghiero F","year":"2018","unstructured":"Rodeghiero F, Pecci A, Balduini CL. Thrombopoietin receptor agonists in hereditary thrombocytopenias. J Thromb Haemost. 2018, 16:1700-10. 10.1111\/jth.14217","journal-title":"J Thromb Haemost"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-304725","article-title":"Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutations","volume":"116","author":"Pecci A","year":"2010","unstructured":"Pecci A, Gresele P, Klersy C, et al.. Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutations. Blood. 2010, 116:5832-7. 10.1182\/blood-2010-08-304725","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-013-1351-7","article-title":"Pathogenesis and management of inherited thrombocytopenias: rationale for the use of thrombopoietin-receptor agonists","volume":"98","author":"Pecci A","year":"2013","unstructured":"Pecci A. Pathogenesis and management of inherited thrombocytopenias: rationale for the use of thrombopoietin-receptor agonists. Int J Hematol. 2013, 98:34-47. 10.1007\/s12185-013-1351-7","journal-title":"Int J Hematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1160\/TH09-01-0068","article-title":"Megakaryocytes of patients with MYH9-related thrombocytopenia present an altered proplatelet formation","volume":"102","author":"Pecci A","year":"2009","unstructured":"Pecci A, Malara A, Badalucco S, Bozzi V, Torti M, Balduini CL, Balduini A. Megakaryocytes of patients with MYH9-related thrombocytopenia present an altered proplatelet formation. Thromb Haemost. 2009, 102:90-6. 10.1160\/TH09-01-0068","journal-title":"Thromb Haemost"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.223966","article-title":"Eltrombopag for the treatment of inherited thrombocytopenias: a phase II clinical trial","volume":"105","author":"Zaninetti C","year":"2020","unstructured":"Zaninetti C, Gresele P, Bertomoro A, et al.. Eltrombopag for the treatment of inherited thrombocytopenias: a phase II clinical trial. Haematologica. 2020, 105:820-8. 10.3324\/haematol.2019.223966","journal-title":"Haematologica"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25500","article-title":"Eltrombopag in preparation for surgery in patients with severe MYH9-related thrombocytopenia","volume":"94","author":"Zaninetti C","year":"2019","unstructured":"Zaninetti C, Barozzi S, Bozzi V, Gresele P, Balduini CL, Pecci A. Eltrombopag in preparation for surgery in patients with severe MYH9-related thrombocytopenia. Am J Hematol. 2019, 94:E199-201. 10.1002\/ajh.25500","journal-title":"Am J Hematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-020-02918-6","article-title":"Eltrombopag to allow chemotherapy in a patient with MYH9-related inherited thrombocytopenia and pancreatic cancer","volume":"112","author":"Paciullo F","year":"2020","unstructured":"Paciullo F, Bury L, Gresele P. Eltrombopag to allow chemotherapy in a patient with MYH9-related inherited thrombocytopenia and pancreatic cancer. Int J Hematol. 2020, 112:725-7. 10.1007\/s12185-020-02918-6","journal-title":"Int J Hematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1213\/XAA.0000000000000621","article-title":"Eltrombopag to treat thrombocytopenia during last month of pregnancy in a woman with MYH9-related disease: a case report","volume":"10","author":"Favier R","year":"2018","unstructured":"Favier R, De Carne C, Elefant E, Lapusneanu R, Gkalea V, Rigouzzo A. Eltrombopag to treat thrombocytopenia during last month of pregnancy in a woman with MYH9-related disease: a case report. A A Pract. 2018, 10:10-12. 10.1213\/XAA.0000000000000621","journal-title":"A A Pract"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2174\/157488610790936196","article-title":"Safety of the thrombopoiesis-stimulating agents for the treatment of immune thrombocytopenia","volume":"5","author":"Cuker A","year":"2010","unstructured":"Cuker A, Chiang EY, Cines DB. Safety of the thrombopoiesis-stimulating agents for the treatment of immune thrombocytopenia. Curr Drug Saf. 2010, 5:171-81. 10.2174\/157488610790936196","journal-title":"Curr Drug Saf"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-373811","article-title":"Romiplostim administration shows reduced megakaryocyte response-capacity and increased myelofibrosis in a mouse model of MYH9-RD","volume":"119","author":"L\u00e9on C","year":"2012","unstructured":"L\u00e9on C, Evert K, Dombrowski F, et al.. Romiplostim administration shows reduced megakaryocyte response-capacity and increased myelofibrosis in a mouse model of MYH9-RD. Blood. 2012, 119:3333-41. 10.1182\/blood-2011-08-373811","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1160\/TH11-07-0474","article-title":"A patient with Fechtner syndrome successfully treated with romiplostim","volume":"107","author":"Gr\u00f6pper S","year":"2012","unstructured":"Gr\u00f6pper S, Althaus K, Najm J, Haase S, Aul C, Greinacher A, Giagounidis A. A patient with Fechtner syndrome successfully treated with romiplostim. Thromb Haemost. 2012, 107:590-1. 10.1160\/TH11-07-0474","journal-title":"Thromb Haemost"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/09537104.2022.2096211","article-title":"Avatrombopag improves thrombocytopenia in MYH9-related disorder following eltrombopag treatment failure","volume":"33","author":"Arif AR","year":"2022","unstructured":"Arif AR, Zhao M, Chen W, Xue M, Luo S, Wang Y. Avatrombopag improves thrombocytopenia in MYH9-related disorder following eltrombopag treatment failure. Platelets. 2022, 33:1307-11. 10.1080\/09537104.2022.2096211","journal-title":"Platelets"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/228535-a-case-of-myosin-heavy-chain-9-related-disorder-following-splenectomy-due-to-misdiagnosis-of-idiopathic-thrombocytopenic-purpura","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T17:01:06Z","timestamp":1709053266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/228535-a-case-of-myosin-heavy-chain-9-related-disorder-following-splenectomy-due-to-misdiagnosis-of-idiopathic-thrombocytopenic-purpura"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,27]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.55064","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,27]]}}}